Pharmaceutical & Drug Injury
Pharmaceutical & Drug Injury
We represent people harmed by pharmaceuticals, biologics, and treatments (including surgical interventions) when the risks were not adequately disclosed – or not disclosed at all. This includes failure-to-warn claims involving drugs such as GLP-1 medications (Ozempic, Wegovy, Mounjaro, and similar products) and other treatments where patients were not told about serious short- and long-term side effects—including gastroparesis, bowel obstruction, vision loss, and related injuries.
Manufacturers and, in some cases, prescribers have a duty to provide accurate information about material risks. When they fail to do so, and a patient is injured as a result, the law provides a path to accountability.
What we handle
Failure-to-warn claims involving GLP-1 drugs and other pharmaceuticals
Cases involving undisclosed or understated serious side effects
Related claims against manufacturers and, where appropriate, prescribing providers
Deceptive Trade Practices Act claims when the information given about the medical intervention was deceptive, inadequate, or unconscionable
If you or a family member has been injured by a drug and believe the risks were not properly disclosed, tell us about your case. We will review it and respond within 48 hours.